Protective effect of bioflavonoid myricetin enhances carbohydrate metabolic enzymes and insulin signaling molecules in streptozotocin-cadmium induced diabetic nephrotoxic rats

Toxicology and Applied Pharmacology

Volumn 279, Issue 2, 2014, Pages 173-185

  Kandasamy, Neelamegam ^a   Ashokkumar, Natarajan ^a  

^a ANNAMALAI UNIVERSITY   (India)

Author keywords

Glucose metabolism; Glucose transporters; Insulin signaling; Myricetin

Indexed keywords

ALBUMIN; CADMIUM; CARBOHYDRATE; CREATININE; FRUCTOSE BISPHOSPHATASE; GLUCOSE; GLUCOSE 6 PHOSPHATASE; GLUCOSE 6 PHOSPHATE DEHYDROGENASE; GLUCOSE TRANSPORTER 2; GLUCOSE TRANSPORTER 4; GLYCOGEN; GLYCOGEN PHOSPHORYLASE; GLYCOGEN SYNTHASE; GLYCOSYLATED HEMOGLOBIN; HEMOGLOBIN; HEXOKINASE; INSULIN; INSULIN RECEPTOR SUBSTRATE 1; INSULIN RECEPTOR SUBSTRATE 2; MYRICETIN; PROTEIN KINASE B; STREPTOZOCIN; UREA; URIC ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARBOHYDRATE METABOLISM; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DIABETIC NEPHROPATHY; ENZYME ACTIVITY; EVALUATION STUDY; FOOD INTAKE; GLUCOSE BLOOD LEVEL; GLUCOSE UTILIZATION; GLYCOGEN MUSCLE LEVEL; HEMOGLOBIN BLOOD LEVEL; IMMUNOREACTIVITY; INSULIN BLOOD LEVEL; INSULIN SIGNALING; KIDNEY FUNCTION; KIDNEY PARENCHYMA; LIVER; MALE; NONHUMAN; OPTIMAL DRUG DOSE; PANCREAS; PROTEIN EXPRESSION; RAT; RENAL PROTECTION; SIGNAL TRANSDUCTION; SKELETAL MUSCLE; UREA BLOOD LEVEL; UREA NITROGEN BLOOD LEVEL; URIC ACID BLOOD LEVEL; WEIGHT CHANGE;

GLUCOSE METABOLISM; GLUCOSE TRANSPORTERS; INSULIN SIGNALING; MYRICETIN;

ALBUMINURIA; ANIMALS; BIOLOGICAL MARKERS; BLOOD GLUCOSE; BLOOD UREA NITROGEN; CADMIUM CHLORIDE; CARBOHYDRATE METABOLISM; CREATININE; DIABETES MELLITUS, EXPERIMENTAL; DIABETIC NEPHROPATHIES; ENZYMES; FLAVONOIDS; HEMOGLOBIN A, GLYCOSYLATED; HYPOGLYCEMIC AGENTS; INSULIN; KIDNEY; LIVER; MALE; MUSCLE, SKELETAL; PANCREAS; RATS; RATS, WISTAR; SIGNAL TRANSDUCTION; UREA; URIC ACID;

EID: 84903712614     PISSN: 0041008X     EISSN: 10960333     Source Type: Journal    
DOI: 10.1016/j.taap.2014.05.014     Document Type: Article

References (80)

1. Baquer N.Z., Gupta D., Rajo J. Regulations of metabolic pathways in liver and kidney during experimental diabetes. Effect of antidiabetic compounds. Indian J. Clin. Biochem. 1998, 13:63-80.
2. Bergmeyer H.U. Glucose-6-Phosphate Dehydrogenase: Methods of Enzymatic Analysis 1984, vol. 2:222-223. Verlag Chemie, Weinheim, Germany.
3. Bolzan A.D., Bianchi M.S. Genotoxicity of streptozotocin. Mutat. Res. 2002, 512:121-134.
4. Bopanna K.N., Kannan J., Sushma G., Balaraman R. Antidiabetic and antihyperglycemic effects of Neem seed kernal powder on alloxan diabetic rabbits. Indian J. Pharmacol. 1997, 29:162-167.
5. Brahmachari G. Bio-flavonoids with promising antidiabetic potentials: a critical survey. Opportunity, Challenge and Scope of Natural Products in Medicinal Chemistry 2011, 187-212. Research Signpost, Kerala. V.K. Tiwari, B.B. Mishra (Eds.).
6. Brandstrup N., Kirk J.E., Brunic C. Determination of glucokinase in tissues. J. Gerontol. 1957, 12:166-171.
7. Brzoska M.M., Moniuszko-Jakoniuk J., Pilat-Marcinkiewicz B., Sawicki B. Liver and kidney function and histology in rats exposed to cadmium and ethanol. Alcohol Alcohol. 2003, 38:2-10.
8. Cao S., Jiang X., Chen J. Effect of zinc (II) on the interactions of bovine serum albumin with flavonols bearing different number of hydroxyl substituent on B-ring. J. Inorg. Biochem. 2010, 104:146-152.
9. Caraway W.T. Determination of uric acid in serum by carbonate method. Am. J. Clin. Pathol. 1955, 25:840-845.
10. Chan H.M., Zhu L.F., Zhong R., Grant D., Goyer R.A., Cherian M.G. Nephrotoxicity in rats following liver transplantation from cadmium exposed rats. Toxicol. Appl. Pharmacol. 1993, 123:89-96.
11. Chapatwala K.D., Boykin M., Butts A., Rajanna B. Effect of intraperitoneally injected cadmium on renal and hepatic gluconeogenic enzymes in rats. Drug Chem. Toxicol. 1982, 5:305-317.
12. Charron M.J., Katz E.B., Olson A.L. GLUT 4 gene regulation and manipulation. J. Biol. Chem. 1999, 274:3253-3256.
13. Chatterjee M.N., Shinde R. Text Book of Medical Biochemistry 2002, 317. Jaypee Brothers, Medical Publishers (P) Ltd., New Delhi. 5th ed.
14. Cheatham B., Vlahos C.J., Cheatham L., Wang L., Blenis J., Kahn C.R. Phosphatidylinositol 3-kinase activation is required for insulin stimulation of pp 70 S6 kinase, DNA synthesis, and glucose transporter translocation. Mol. Cell. Biol. 1994, 14:4902-4911.
15. Dalla Vestra M., Saller A., Bortolosco E., Mauer M., Fioretto P. Structural involvement in type 1 and type 2 diabetic nephropathy. Diabetes Metab. 2000, 26:8-14.
16. DeFronzo R.A., Bonadonna R.C., Ferrannini E. Pathogenesis of NIDDM. A balanced overview. Diabetes Care 1992, 15:318-368.
17. Doumas B.T., Watson W.A., Biggs H.G. Albumin standards and the measurement of serum albumin with bromocresol green. Clin. Chem. Acta. 1971, 31:87-96.
18. Egawa K., Maegawa H., Shimizu S., Morino K., Nishio Y., Bryer-Ash M. Proteintyrosine phosphatase-1B negatively regulates insulin signaling in l6 myocytes and Fao hepatoma cells. J. Biol. Chem. 2001, 276:10207-10211.
19. Fawcett J.K., Scott J.E. A rapid and precise method for the determination of urea. J. Clin. Pathol. 1960, 3:156-159.
20. Fiske C.H., Subbarow Y. The colorimetric determination of phosphorus. J. Biol. Chem. 1925, 66:375-400.
21. Gall M.A., Hougaard P., Borch-Johnsen K., Parving H.H. Risk factors for development of incipient and overt diabetic nephropathy in patients with non-insulin dependent diabetes mellitus: prospective, observational study. BMJ 1997, 314:783-788.
22. Gancedo J.M., Gancedo C. Fructose 1,6-diphosphatase, phosphofructokinase and glucose 6-phosphate dehydrogenase from fermenting and nonfermenting yeasts. Arch. Microbiol. 1971, 76:132-138.
23. Giordano E., Bosco D., Cirulli V., Meda P. Repeated glucose stimulation reveals distinct and lasting secretion patterns of individual rat pancreatic p-cells. J. Clin. Invest. 1991, 87:2178-2185.
24. Golden S., Wals P.A., Katz J. An improved procedure for the assay of glycogen synthase and phosphorylase in rat liver homogenates. Anal. Biochem. 1977, 77:436-445.
25. Hamada T., Tanimoto A., Arima N., Ide Y., Sasaguri T., Shimajiri S., Sasaguri Y. Altered membrane skeleton of red blood cells participates in cadmium-induced anemia. Biochem. Mol. Biol. Int. 1998, 45:841-847.
26. Han J.C., Park S.Y., Hah B.G., Choi G.H., Kim Y.K., Kwon T.H., Kim E.K., Lachaal M., Jung C.Y., Lee W. Cadmium induces impaired glucose tolerance in rat by down-regulating GLUT4 expression in adipocytes. Arch. Biochem. Biophys. 2003, 413:213-220.
27. Harnly J.M., Doherty R.F., Beecher G.R., Holden J.M., Haytowitz D.B., Bhagwat S., Gebhardt S. Flavonoid content of U.S. fruits, vegetables, and nuts. J. Agric. Food Chem. 2006, 54:9966-9977.
28. Havu N. Sulfhydryl inhibitors and pancreatic islet tissue. Acta Endocrinol. Suppl. 1969, 139:1-231.
29. Huang S., Czech M.P. The GLUT4 glucose transporter. Cell Metab. 2007, 5:237-252.
30. Jaffe M. Concerning the precipitate produced in normal urine by picric acid and a new reaction of creatinine. Z. Physiol. Chem. 1886, 10:391-400.
31. Jefferson J.A., Shankland S.J., Pichler R.H. Proteinuria in diabetic kidney disease: a mechanistic view point. Kidney Int. 2008, 74:22-36.
32. Jin T., Nordberg G., Sehlin J., Wallin H., Sandberg S. The susceptibility to nephrotoxicity of STZ-induced diabetic rats subchronically exposed to cadmium chloride in drinking water. Toxicology 1999, 142:69-75.
33. Jun X.H., Shu M.W., Rong L.F., Hui X.J., Fang L.Q., Jun F.W. Radical scavenging activity of myricetin. Acta Phys. -Chim. Sin. 2013, 29:1421-1432.
34. Kandasamy N., Ashokkumar N. Myricetin, a natural flavonoid, normalizes hyperglycemia in streptozotocin-cadmium induced experimental diabetic nephrotoxic rats. Biomed. Prev. Nutr. 2012, 2:246-251.
35. Kandasamy N., Ashokkumar N. Myricetin modulates streptozotocin-cadmium induced oxidative stress in long term experimental diabetic nephrotoxic rats. J. Funct. Foods 2013, 10.1016/j.jff.2013.06.004.
36. Kanter M., Yoruk M., Koc A., Meral I., Karaca T. Effects of cadmium exposure on morphological aspects of pancreas, weights of fetus and placenta in streptozotocin-induced diabetic pregnant rats. Biol. Trace Elem. Res. 2003, 93:189-200.
37. Kiekens R., In't Veld P., Mahier T., Schuit F., Winkel M.V.D., Pipeleers D. Differences in glucose recognition by individual rat pancreatic p-cells are associated with intercellular differences in glucose induced biosynthetic activity. J. Clin. Invest. 1992, 89:117-125.
38. Kim S.C., Sprung R., Chen Y., Xu Y., Ball H., Pei J., Cheng T., Kho Y., Xiao H., Xiao L., Grishin N.V., White M., Yang X.J., Zhao Y. Substrate and functional diversity of lysine acetylation revealed by a proteomics survey. Mol. Cell 2006, 23:607-618.
39. Klapcinska B., Poprzecki S., Dolezych B., Kimsa E. Cadmium-induced changes in hematology and 2,3-DPG levels in rats. Bull. Environ. Contam. Toxicol. 2000, 64:93-99.
40. Koide H., Oda T. Pathological occurrence of glucose 6-phosphatase in serum in liver diseases. Clin. Chim. Acta 1956, 4:554-561.
41. Kong Q.H. Human health effects for environmental cadmium pollution. J. Zhejiang Acad. Med. Sci. 2001, 12:1-2.
42. Kwon O., Eck P., Chen S., Corpe C.P., Lee J., Kruhlak M., Levine M. Inhibition of the intestinal glucose transporter GLUT-2 by flavonoids. FASEB J. 2007, 21:366-377.
43. Laemmli U.K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970, 227:680-685.
44. Leahy J.L., Bonner-Weir S., Weir G.C. Beta-cell dysfunction induced by chronic hyperglycemia. Current ideas on mechanism of impaired glucose induced insulin secretion. Diabetes Care 1992, 15:442-455.
45. Lei L.J., Jin T.Y., Zhou Y.F. The toxic effects of cadmium on pancreas. Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi 2005, 23:45-49.
46. Li W., Dai Y.H., Yu Y.H., Li L., Wu C.M., Luan W.W., Meng W.W., Zhang X.S., Deng Y.L. Antihyperglycemic effect of Cephalotaxus sinensis leaves and GLUT-4 translocation facilitating activity of its flavonoid constituents. Biol. Pharm. Bull. 2007, 30:1123-1129.
47. Liu I.M., Liou S.S., Lan T.W., Hsu F.L., Cheng J.T. Myricetin as the active principle of Abelmoschus moschatus to lower plasma glucose in streptozotocin-induced diabetic rats. Planta Med. 2005, 71:617-621.
48. Lowry O.H., Rosebrough N.J., Farr A.L., Randall R.J. Protein measurement with Folin phenol reagent. J. Biol. Chem. 1951, 193:265-275.
49. Merali Z., Kacew S., Singhal R.L. Response of hepatic carbohydrate and cyclic AMP metabolism to cadmium treatment in rats. Can. J. Physiol. Pharmacol. 1975, 53:174-184.
50. Miean K.H., Mohamed S. Flavonoid (myricetin, quercetin, kaempferol, luteolin, and apigenin) content of edible tropical plants. J. Agric. Food Chem. 2001, 49:3106-3112.
51. Mira L., Fernandez M.T., Santos M., Rocha R., Florenchio M.H., Jennings K.R. Interactions of flavonoids with iron and copper ions: a mechanism for their antioxidant activity. Free Radic. Res. 2002, 36:1199-1208.
52. Montoro P., Tuberoso C.I., Piacente S., Perrone A., De Feo V., Cabras P., Pizza C. Stability and antioxidant activity of polyphenols in extracts of Myrtus communis L. berries used for the preparation of myrtle liqueur. J. Pharm. Biomed. Anal. 2006, 41:1614-1619.
53. Morales M.A., Jabbagy A.J., Terenzi H.P. Mutations affecting accumulation of glycogen. Neurospora Newsl. 1975, 20:24-25.
54. Nordberg G.F., Goyer R., Nordberg M. Comparative toxicity of cadmium-metallothionein and cadmium chloride on mouse kidney. Arch. Pathol. 1975, 99:192-197.
55. Olmo R., Blanco M.D., Teijon C., Socorro J.M., Teijon J.M. Modifications induced by zinc, cadmium and mercury acetates on hexokinase in aqueous-solutions. Polym. Int. 1998, 47:179-185.
56. Ong K.C., Khoo H.E. Insulinomimetic effects of myricetin on lipogenesis and glucose transport in rat adipocytes but not glucose transport translocation. Biochem. Pharmacol. 1996, 51:423-429.
57. Pederson B.A., Schroeder J.M., Parker G.E., Smith M.W., DePaoli-Roach A.A., Roach P.J. Glucose metabolism in mice lacking muscle glycogen synthase. Diabetes 2005, 54:3466-3473.
58. Rasch R. Prevention of diabetic glomerulopathy in streptozotocin diabetic rats by insulin treatment. Diabetologia 1980, 18:413-416.
59. Rodrigo R., Rivera G. Renal damage mediated by oxidative stress: a hypothesis of protective effects of red wine. Free Radic. Biol. Med. 2002, 33:409-422.
60. Sasaki T., Matsy S., Sonae A. Effect of acetic acid concentration on the colour reaction in the o-toluidine boric acid method for blood glucose estimation. Rinsho Kagaku 1972, 1:346-353.
61. Sheela C.G., Augusti K.T. Antidiabetic effects of S-allyl cysteine sulphoxide isolated from garlic Allium sativum Linn. Indian J. Exp. Biol. 1992, 30:523-526.
62. Shull K.H., Ashmore J., Mayer J. Hexokinase, glucose-6-phosphatase and phosphorylase levels in hereditarily obese-hyperglycemic mice. Arch. Biochem. Biophys. 1956, 62:210-216.
63. Siddique O., Sun Y., Lin J.C., Chein Y.W. Facilitated transdermal transport of insulin. J. Pharmacol. Sci. 1987, 76:341-345.
64. Sochar M., Baquer N.Z., Mclean P. Glucose under utilization in diabetes. Comparative studies on the changes in the activities of enzymes of glucose metabolism in rat kidney and liver. Mol. Physiol. 1985, 7:51-68.
65. Szkudelski T. The mechanism of alloxan and streptozotocin action in b-cells of the rat pancreas. Physiol. Res. 2001, 50:537-546.
66. Taniguchi C.M., Emanuelli B., Kahn C.R. Critical nodes in signalling pathways: insights into insulin action. Nat. Rev. Mol. Cell Biol. 2006, 7:85-96.
67. Thorens B., Waeber G. GLUT-2 function, expression and transcriptional regulation in liver and pancreatic b cells. Facilitative Glucose Transporters 1997, 167-168. G.W. Gould (Ed.).
68. Thorens B., Sarkar H.K., Kaback H.R., Lodish H.F. Cloning and functional expression in bacteria of a novel glucose transporter present in liver, intestine, kidney, and β-pancreatic islet cells. Cell 1988, 55:281-290.
69. Tietz N.W. Fundamentals of Clinical Chemistry 1987, 638. WB Saunders Company, Philadelphia.
70. Trinder P. Plasma glucose was measured by standard methods. Ann. Clin. Biochem. 1969, 6:24-27.
71. Tsuruoka S., Sugimoto K., Muto S., Nomiyama K., Fujimura A., Imai M. Acute effect of cadmium-metallothionein on glucose and amino acid transport across the apical membrane of the rabbit proximal tubule perfused in vitro. J. Pharmacol. Exp. Ther. 2000, 292:769-777.
72. Ugochukwu N.H., Babady N.E. Antihyperglycemic effect of aqueous and ethanolic extracts of Gongronema latifolium leaves on glucose and glycogen metabolism in livers of normal and streptozotocin-induced diabetic rats. Life Sci. 2003, 29:1925-1938.
73. USRDS (United State Renal Data System) USRDS 2003 Annual Data Report: Atlas of End-stage Renal Disease in the United States 2003, National Institute of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD.
74. Vats V., Yadav S.P., Grover J.K. Effect of Trigonella foenum graecum on glycogen content of tissues and the key enzymes of carbohydrate metabolism. J. Ethnopharmacol. 2003, 85:237-242.
75. Vessal M., Hemmati M., Vasei M. Antidiabetic effects of quercetin in streptozocin induced diabetic rats. Comp. Biochem. Physiol. C 2003, 135:357-364.
76. Vitale A.M., Monserrat J.M., Castilho P., Rodriguez E.M. Inhibitory effects of cadmium on carbonic anhydrase activity and ionic regulation of the estuarine crab Chasmagnathus granulata (Decapoda, Grapsidae). Comp. Biochem. Physiol. 1999, 122:121-129.
77. Wang Z.H., Kang K.A., Zhang R., Piao M.J., Jo S.H., Kim J.S., Sang S.S., Lee J.S., Park D.H., Hyun J.W. Myricetin suppresses oxidative stress-induced cell damage via both direct and indirect antioxidant action. Environ. Toxicol. Pharmacol. 2010, 29:12-18.
78. Watkins D.T., Moore M. Effects of sulfhydryl binding reagents on insulin release from isolated secretion granules. Endocrinology 1974, 96:485-491.
79. WHO (World Health Organization) Environmental Health Criteria 134. Cadmium 1992, International Programme on Chemical Safety (IPCS), WHO, Geneva.
80. Zdychova J., Komers R. Emerging role of Akt kinase/protein kinase B signaling in pathophysiology of diabetes and its complications. Physiol. Res. 2005, 54:1-16.